News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Naveen Pemmaraju: Azacitidine, Venetoclax and Magrolimab in Newly Diagnosed and Relapsed AML
Naveen Pemmaraju/mdanderson.org
Apr 29, 2025, 09:33

Naveen Pemmaraju: Azacitidine, Venetoclax and Magrolimab in Newly Diagnosed and Relapsed AML

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared an article by Naval Daver, et al. on X:

“Azacitidine, Venetoclax and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase 1b/2 Study and Correlative Analysis | Led by Naval Daver and Hussein Abbas.”

Azacitidine, Venetoclax and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase 1b/2 Study and Correlative Analysis.

Journal: Clinical Cancer Research.

Authors: Naval Daver, et al.

Naveen Pemmaraju: Azacitidine, Venetoclax and Magrolimab in Newly Diagnosed and Relapsed AML

More posts featuring Naveen Pemmaraju.

AML azacitidine BPDCN Program cancer fight against cancer Global fight against cancer Hussein Abbas magrolimab MD Anderson Cancer Center Naval Daver Naveen Pemmaraju OncoDaily Oncology University of Texas venetoclax
Special Coverage
Blog
Apr 29, 2025, 09:33
Naveen Pemmaraju: Azacitidine, Venetoclax and Magrolimab in Newly Diagnosed and Relapsed AML
Blog
Apr 29, 2025, 09:23
Chris Poulios: The Young Cancer Professionals group of the European Cancer Organisation
Blog
Apr 29, 2025, 09:16
Navneet Majhail: Congratulations to Stephen Strickland for presenting first-in-human results of SENTI-202
Blog
Apr 29, 2025, 09:10
Ahmed Magdy Rabea: An incredible privilege to participate in the 4th SOH Conference
Blog
Apr 29, 2025, 09:02
Isabel Mestres Announces Candidacy for NCD Alliance Board of Directors 2025–2027
Blog
Apr 29, 2025, 08:54
Women and Cancer: Prevention, Information and Hope - Yale Cancer Center
Blog
Apr 29, 2025, 08:14
Transforming cancer OUtcomes through Research - Consultancy and analytics: Guy’s Cancer cohort
Blog
Apr 29, 2025, 07:50
Petros Grivas: Congratulations to all speakers at The American Urological Association Meeting
Dialogues
Apr 29, 2025, 07:48
OnCoffee: Brian Chernak on Cancer, Baseball, Architecture, and Work-Life Balance
Blog
Apr 29, 2025, 07:40
Margaret Foti: A pleasure to see everyone at the Korean Researchers Networking Night at AACR25
Dialogues
Apr 29, 2025, 07:34
Empowering Oncologists: How did we set up research infrastructure in the community?
Blog
Apr 29, 2025, 07:00
Wafik S. El-Deiry: Johanna Joyce on tumor immune microenvironment in brain tumors and brain metastases